ConductScience.org, home

Paper945166

Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice.

Horowski R and 1 other. Eur J Pharmacol, 1976. Cited by 160 papers, by iCite.

Cite this record

ConductScience Library. Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice. Papers, record 945166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/945166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice.
PubMed
Journal
Eur J Pharmacol
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
160
iCite
Relative citation ratio, by iCite
8.28
iCite
Revised in PubMed
2019-06-23
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Horowski RR
2Wachtel HH

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DopamineMajor topic
ErgolinesMajor topic
Animals
Apomorphine
Body Temperature
Catecholamines
Dextroamphetamine
Female
Haloperidol
Humans
Male
Methyltyrosines
Mice
Mice, Inbred Strains
Motor Activity
Norepinephrine
Reserpine
Stereotyped Behavior
Urea

Source PubMed

Download CSV of topics

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 160 citations.

PMIDTitleJournalYearIn PapersSource
37900918The G protein biased serotonin 5-HT2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice.Front Mol Biosci2023https://conductscience.org/library/papers/37900918PubMed
37796288L-DOPA-therapy in Parkinson's disease: some personal reflections on L-DOPA therapy from Vienna and Berlin.J Neural Transm (Vienna)2023https://conductscience.org/library/papers/37796288PubMed
35204744Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson's Disease.Biomolecules2022https://conductscience.org/library/papers/35204744PubMed
30805732Classical dopamine agonists.J Neural Transm (Vienna)2019https://conductscience.org/library/papers/30805732PubMed
16897593A history of dopamine agonists. From the physiology and pharmacology of dopamine to therapies for prolactinomas and Parkinson's disease - a subjective view.J Neural Transm (Vienna)2007https://conductscience.org/library/papers/16897593PubMed
11734100Progressive Myoclonic Epilepsies.Curr Treat Options Neurol2002https://conductscience.org/library/papers/11734100PubMed
9829165Clinical pharmacology of dopamine agonists in Parkinson's disease.Drugs Aging1998https://conductscience.org/library/papers/9829165PubMed
7308272Radioimmunoassay of plasma lisuride in man following intravenous and oral administration of lisuride hydrogen maleate: effect on plasma prolactin level.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7308272PubMed
7308240The pharmacokinetics of lisuride hydrogen maleate in rat, rabbit and rhesus monkey.Eur J Drug Metab Pharmacokinet1981https://conductscience.org/library/papers/7308240PubMed
7264624Transitional states of central serotonin receptors in Parkinson's disease.J Neural Transm1981https://conductscience.org/library/papers/7264624PubMed
7264623The effects of lisuride and some other dopaminergic agonists on receptor binding in human brain.J Neural Transm1981https://conductscience.org/library/papers/7264623PubMed
7241162The use of lisuride in the treatment of multiple system atrophy with autonomic failure (Shy-Drager syndrome).J Neurol Neurosurg Psychiatry1981https://conductscience.org/library/papers/7241162PubMed
7130971Effects of pergolide and bromocriptine on male rat sexual behavior.J Neural Transm1982https://conductscience.org/library/papers/7130971PubMed
6777796Effects of lisuride on body temperature of rats and rabbits: relation to microsomal biotransformation and dopaminergic receptor stimulation.Psychopharmacology (Berl)1980https://conductscience.org/library/papers/6777796PubMed
6771795[Psychopharmacological profile of a new dopaminergic agonist, RU 24213 (author's transl)].Psychopharmacology (Berl)1980https://conductscience.org/library/papers/6771795PubMed
6713512Primary tissue culture of human adrenocortical Conn's adenomata. Bromocriptine as a possible agonist-antagonist of angiotensin at the cellular level.Cell Tissue Res1984https://conductscience.org/library/papers/6713512PubMed
6437857The pharmacology of Parkinson's disease: basic aspects and recent advances.Experientia1984https://conductscience.org/library/papers/6437857PubMed
6435991Anti-parkinsonian drugs today.Drugs1984https://conductscience.org/library/papers/6435991PubMed
6419256Habituation of aggression in mice: pharmacological evidence of catecholaminergic and serotonergic mediation.Psychopharmacology (Berl)1983https://conductscience.org/library/papers/6419256PubMed
6408668The role of dopaminergic receptors in the behavioral effects induced by lisuride in male rats.Psychopharmacology (Berl)1983https://conductscience.org/library/papers/6408668PubMed

See all 33 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/945166

GET https://conductscience.org/api/papers/v1/945166/cited_by?page=2